Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

53.68
BATS BZX Real-Time Price
As of 10:42am ET
 -0.14 / -0.26%
Today’s Change
43.23
Today|||52-Week Range
56.50
+0.28%
Year-to-Date
ZTS Regular Dividend: ZTS will begin trading ex-dividend on 04/04/17 with a $0.105 dividend payable to shareholders of record as of 04/06/17.
Impax Gains 38% On CEO Appointment, Talk of Sale
Mar 27 / TheStreet.com - Paid Partner Content
Why Is Zoetis (ZTS) Up 3.1% Since the Last Earnings Report?
Mar 21 / Zacks.com - Paid Partner Content
Merck Closes Acquisition of Controlling Stake in Vallee S.A
Mar 23 / Zacks.com - Paid Partner Content
Trump's pledge on drug pricing squeezes pharma stocks
Mar 07 / FT.com - Paid Partner Content

Today’s Trading

Previous close53.82
Today’s open53.71
Day’s range53.54 - 53.75
Volume20,102
Average volume (3 months)3,237,685
Market cap$26.5B
Dividend yield0.78%
Data as of 10:42am ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+18.13%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+2.58%
P/E ratio32.4
Price/Sales5.46
Price/Book17.84

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.93+0.86%
ALXNAlexion Pharmaceutic...+0.49+0.41%
BAXBaxter International...+0.03+0.05%
INCYIncyte Corp+0.11+0.08%
Data as of 10:42am ET, 03/30/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs